Modulation of inflammatory pathways by the immune cholinergic system

Eran Nizri, Talma Brenner*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

54 Scopus citations


Research done in the past years pointed to a novel function of cholinergic transmission. It has been shown that cholinergic transmission can modulate various aspects of the immune function, whether innate or adaptive. Cholinergic transmission affects immune cell proliferation, cytokine production, T helper differentiation and antigen presentation. Theses effects are mediated by cholinergic muscarinic and nicotinic receptors and other cholinergic components present in immune cells, such as acetylcholinesterase (AChE) and cholineacetyltransferase. The α7 nicotinic acetylcholine receptor was designated anti-inflammatory activity and has shown promise in pre-clinical models of inflammatory disorders. We herein describe the various components of the immune cholinergic system, and specifically the immune suppressive effects of α7 activation. This activation can be accomplished either by direct stimulation or indirectly, by inhibition of AChE. Thus, the presence of the immune cholinergic system can pave the way for novel immunomodulatory agents, or to the broadening of use of known cholinergic agents.

Original languageEnglish
Pages (from-to)73-85
Number of pages13
JournalAmino Acids
Issue number1
StatePublished - Jul 2013
Externally publishedYes


FundersFunder number
Israel Ministry of Health Chief Scientist Fund


    • Acetylcholinesterase inhibitors
    • Multiple sclerosis
    • Myasthenia gravis
    • Neuroinflammation
    • α7 nicotinic acetylcholine receptor


    Dive into the research topics of 'Modulation of inflammatory pathways by the immune cholinergic system'. Together they form a unique fingerprint.

    Cite this